231 related articles for article (PubMed ID: 33526983)
1. Src-family Protein Tyrosine Kinases: A promising target for treating Cardiovascular Diseases.
Zhai Y; Yang J; Zhang J; Yang J; Li Q; Zheng T
Int J Med Sci; 2021; 18(5):1216-1224. PubMed ID: 33526983
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of Src family kinases and therapeutic implications of their modulators.
Kumar A; Jaggi AS; Singh N
Fundam Clin Pharmacol; 2015 Apr; 29(2):115-30. PubMed ID: 25545125
[TBL] [Abstract][Full Text] [Related]
3. Pyrazolo pyrimidine-type inhibitors of SRC family tyrosine kinases promote ovarian steroid-induced differentiation of human endometrial stromal cells in vitro.
Maruyama T; Yamamoto Y; Shimizu A; Masuda H; Sakai N; Sakurai R; Asada H; Yoshimura Y
Biol Reprod; 2004 Jan; 70(1):214-21. PubMed ID: 14522827
[TBL] [Abstract][Full Text] [Related]
4. Allosteric networks governing regulation and catalysis of Src-family protein tyrosine kinases: implications for disease-associated kinases.
Cheng HC; Johnson TM; Mills RD; Chong YP; Chan KC; Culvenor JG
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):93-101. PubMed ID: 19566834
[TBL] [Abstract][Full Text] [Related]
5. Src-family protein tyrosine kinases: A promising target for treating chronic pain.
Ge MM; Zhou YQ; Tian XB; Manyande A; Tian YK; Ye DW; Yang H
Biomed Pharmacother; 2020 May; 125():110017. PubMed ID: 32106384
[TBL] [Abstract][Full Text] [Related]
6. Src family kinases and pulmonary fibrosis: A review.
Li H; Zhao C; Tian Y; Lu J; Zhang G; Liang S; Chen D; Liu X; Kuang W; Zhu M
Biomed Pharmacother; 2020 Jul; 127():110183. PubMed ID: 32388241
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
Mao L; Deng WW; Yu GT; Bu LL; Liu JF; Ma SR; Wu L; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2017 Mar; 140(5):1173-1185. PubMed ID: 27798955
[TBL] [Abstract][Full Text] [Related]
8. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
Chong YP; Ia KK; Mulhern TD; Cheng HC
Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
[TBL] [Abstract][Full Text] [Related]
9. Novel patented SRC kinase inhibitor.
Lu XL; Liu XY; Cao X; Jiao BH
Curr Med Chem; 2012; 19(12):1821-9. PubMed ID: 22414081
[TBL] [Abstract][Full Text] [Related]
10. The role of Src in solid tumors.
Wheeler DL; Iida M; Dunn EF
Oncologist; 2009 Jul; 14(7):667-78. PubMed ID: 19581523
[TBL] [Abstract][Full Text] [Related]
11. Recent progress of Src SH2 and SH3 inhibitors as anticancer agents.
Lu XL; Cao X; Liu XY; Jiao BH
Curr Med Chem; 2010; 17(12):1117-24. PubMed ID: 20158477
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones.
Crossthwaite AJ; Valli H; Williams RJ
J Neurochem; 2004 Mar; 88(5):1127-39. PubMed ID: 15009668
[TBL] [Abstract][Full Text] [Related]
13. Activated Src kinases interact with the N-methyl-D-aspartate receptor after neonatal brain ischemia.
Jiang X; Mu D; Biran V; Faustino J; Chang S; Rincón CM; Sheldon RA; Ferriero DM
Ann Neurol; 2008 May; 63(5):632-41. PubMed ID: 18384166
[TBL] [Abstract][Full Text] [Related]
14. Src family kinases play multiple roles in differentiation of trophoblasts from human term placenta.
Daoud G; Rassart E; Masse A; Lafond J
J Physiol; 2006 Mar; 571(Pt 3):537-53. PubMed ID: 16410281
[TBL] [Abstract][Full Text] [Related]
15. Role of co- and post-translational modifications of SFKs in their kinase activation.
Cai ML; Wang MY; Zhang CH; Wang JX; Liu H; He HW; Zhao WL; Xia GM; Shao RG
J Drug Target; 2020 Jan; 28(1):23-32. PubMed ID: 31094236
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.
Winiarska M; Bojarczuk K; Pyrzynska B; Bil J; Siernicka M; Dwojak M; Bobrowicz M; Miazek N; Zapala P; Zagozdzon A; Krol M; Syta A; Podszywalow-Bartnicka P; Pilch Z; Dabrowska-Iwanicka A; Juszczynski P; Efremov DG; Slabicki M; Zenz T; Le Roy A; Olive D; Rygiel TP; Leusen JH; Golab J
MAbs; 2014; 6(5):1300-13. PubMed ID: 25517315
[TBL] [Abstract][Full Text] [Related]
17. The role of Src in prostate cancer.
Fizazi K
Ann Oncol; 2007 Nov; 18(11):1765-73. PubMed ID: 17426060
[TBL] [Abstract][Full Text] [Related]
18. How ATP-Competitive Inhibitors Allosterically Modulate Tyrosine Kinases That Contain a Src-like Regulatory Architecture.
Fang L; Vilas-Boas J; Chakraborty S; Potter ZE; Register AC; Seeliger MA; Maly DJ
ACS Chem Biol; 2020 Jul; 15(7):2005-2016. PubMed ID: 32479050
[TBL] [Abstract][Full Text] [Related]
19. Activation of the lutropin/choriogonadotropin receptor in MA-10 cells leads to the tyrosine phosphorylation of the focal adhesion kinase by a pathway that involves Src family kinases.
Mizutani T; Shiraishi K; Welsh T; Ascoli M
Mol Endocrinol; 2006 Mar; 20(3):619-30. PubMed ID: 16293639
[TBL] [Abstract][Full Text] [Related]
20. The focal adhesion kinase Pyk2 links Ca2+ signalling to Src family kinase activation and protein tyrosine phosphorylation in thrombin-stimulated platelets.
Canobbio I; Cipolla L; Guidetti GF; Manganaro D; Visconte C; Kim S; Okigaki M; Falasca M; Kunapuli SP; Torti M
Biochem J; 2015 Jul; 469(2):199-210. PubMed ID: 25967238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]